Voloridge Investment Management’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-188,776
| Closed | -$7.44M | – | 1372 |
|
|
2025
Q1 | $7.44M | Buy |
+188,776
| New | +$7.44M | 0.03% | 667 |
|
|
2023
Q4 | – | Sell |
-1,612,534
| Closed | -$13.5M | – | 1468 |
|
|
2023
Q3 | $13.5M | Buy |
1,612,534
+958,954
| +147% | +$8.02M | 0.07% | 379 |
|
|
2023
Q2 | $16.2M | Sell |
653,580
-559,959
| -46% | -$13.9M | 0.08% | 341 |
|
|
2023
Q1 | $18.3M | Buy |
1,213,539
+34,066
| +3% | +$512K | 0.09% | 308 |
|
|
2022
Q4 | $14M | Buy |
1,179,473
+375,104
| +47% | +$4.44M | 0.08% | 343 |
|
|
2022
Q3 | $4.76M | Sell |
804,369
-79,947
| -9% | -$473K | 0.03% | 667 |
|
|
2022
Q2 | $3.76M | Sell |
884,316
-241,007
| -21% | -$1.02M | 0.02% | 783 |
|
|
2022
Q1 | $10.7M | Buy |
1,125,323
+668,197
| +146% | +$6.35M | 0.06% | 395 |
|
|
2021
Q4 | $8.69M | Buy |
+457,126
| New | +$8.69M | 0.05% | 510 |
|
|
2021
Q1 | – | Sell |
-41,814
| Closed | -$2.18M | – | 1660 |
|
|
2020
Q4 | $2.18M | Buy |
+41,814
| New | +$2.18M | 0.02% | 708 |
|
|
2020
Q2 | – | Sell |
-34,846
| Closed | -$343K | – | 1493 |
|
|
2020
Q1 | $343K | Buy |
34,846
+12,277
| +54% | +$121K | 0.01% | 824 |
|
|
2019
Q4 | $251K | Buy |
+22,569
| New | +$251K | ﹤0.01% | 966 |
|